2/10
01:00 pm
phio
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.
High
Report
Phio Pharmaceuticals (NASDAQ:PHIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $14.00 price target on the stock.